Edap Tms (FOCL) Return on Capital Employed (2020 - 2026)
Edap Tms' (FOCL) quarterly Return on Capital Employed came in at 67.59% in Q1 2026, down 2128.0% YoY from 3.33% in Q1 2025, and down 5.39% on a QoQ basis from 64.13% in Q4 2025.
Edap Tms (FOCL) Return on Capital Employed (2020 - 2026) Analysis & Trends
Edap Tms (FOCL) has 7 years of Return on Capital Employed data on file, last reported at 67.59% in Q1 2026.
- Quarterly Return on Capital Employed fell 2128.0% year-over-year to 67.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 67.59% (down 2128.0% YoY) and the FY2025 annual result came in at 52.47%, down 1333.0% from the prior year.
- Return on Capital Employed slipped to 67.59% in Q1 2026, from 64.13% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 3.03% in Q3 2022 to a low of 67.59% in Q1 2026.
- A 5-year average of 32.21% and a median of 31.11% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed plunged 248 bps — and 2023, when it sank 2572 bps.
- Tracing FOCL's Return on Capital Employed over 5 years: stood at 5.39% in 2022, then tumbled by 477 bps to 31.11% in 2023, then plunged by 44 bps to 44.73% in 2024, then tumbled by 43 bps to 64.13% in 2025, then declined by 5 bps to 67.59% in 2026.
- The last three Return on Capital Employed figures came in at 67.59% (Q1 2026), 64.13% (Q4 2025), and 57.36% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 43.39% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 12.93% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 19.96% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 8.66% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -74.44% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 1.84% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -6.99% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -67.72% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 0.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67.59% |
| Dec 31, 2025 | -64.13% |
| Sep 30, 2025 | -57.36% |
| Jun 30, 2025 | -57.41% |
| Mar 31, 2025 | -46.30% |
| Dec 31, 2024 | -44.73% |
| Sep 30, 2024 | -39.80% |
| Jun 30, 2024 | -34.46% |
| Mar 31, 2024 | -29.32% |
| Dec 31, 2023 | -31.11% |
| Sep 30, 2023 | -26.07% |
| Jun 30, 2023 | -19.45% |
| Mar 31, 2023 | -14.51% |
| Dec 31, 2022 | -5.39% |
| Sep 30, 2022 | -3.03% |
| Jun 30, 2022 | -3.53% |
| Mar 31, 2022 | -3.39% |
| Dec 31, 2021 | -2.89% |
| Sep 30, 2021 | -0.56% |
| Jun 30, 2021 | 0.32% |